Style | Citing Format |
---|---|
MLA | Tavakolpour S. "Tofacitinib As the Potent Treatment for Refractory Pemphigus: A Possible Alternative Treatment for Pemphigus." Dermatologic Therapy, vol. 31, no. 5, 2018, pp. -. |
APA | Tavakolpour S (2018). Tofacitinib As the Potent Treatment for Refractory Pemphigus: A Possible Alternative Treatment for Pemphigus. Dermatologic Therapy, 31(5), -. |
Chicago | Tavakolpour S. "Tofacitinib As the Potent Treatment for Refractory Pemphigus: A Possible Alternative Treatment for Pemphigus." Dermatologic Therapy 31, no. 5 (2018): -. |
Harvard | Tavakolpour S (2018) 'Tofacitinib As the Potent Treatment for Refractory Pemphigus: A Possible Alternative Treatment for Pemphigus', Dermatologic Therapy, 31(5), pp. -. |
Vancouver | Tavakolpour S. Tofacitinib As the Potent Treatment for Refractory Pemphigus: A Possible Alternative Treatment for Pemphigus. Dermatologic Therapy. 2018;31(5):-. |
BibTex | @article{ author = {Tavakolpour S}, title = {Tofacitinib As the Potent Treatment for Refractory Pemphigus: A Possible Alternative Treatment for Pemphigus}, journal = {Dermatologic Therapy}, volume = {31}, number = {5}, pages = {-}, year = {2018} } |
RIS | TY - JOUR AU - Tavakolpour S TI - Tofacitinib As the Potent Treatment for Refractory Pemphigus: A Possible Alternative Treatment for Pemphigus JO - Dermatologic Therapy VL - 31 IS - 5 SP - EP - PY - 2018 ER - |